Since human beta 3–adrenoceptor agonists share half of their amino-acid sequences with beta 1- and beta 2-adrenoceptor agonists, cross-reactivity can occur, which can result in arrhythmias ...

(HealthDay)—For patients with chronic obstructive pulmonary disease (COPD), new initiation of inhaled long-acting β 2-agonists (LABAs ... was associated with a 1.5- and 1.52-fold increased ...

GLP-1, and glucagon Receptors, improves markers of pancreatic beta-cell function and insulin sensitivity" ADA 2024; 266-OR.

today announced the initiation of dosing in a Phase 1 clinical trial evaluating TERN-501, a selective thyroid hormone receptor beta (THR-β) agonist with high metabolic stability, enhanced liver ...

I really didn't see the death of short-acting beta-agonists (SABAs) coming. Sure, I'd read the SYGMA trials, [1,2] and yes, I was aware of lobbying from the "other side of the pond" (Europe).

Terns Pharmaceuticals announced positive top-line results from a phase 1 clinical trial of TERN-501, a thyroid hormone receptor beta agonist for the treatment of nonalcoholic steatohepatitis ...

Although beta-2 agonists have been associated with a reduced risk of Parkinson's disease in some previous epidemiological studies, this association was not found in a recent register-based study ...